Bennevolance Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -61.72%
- Profit Growth -24.30%
- Ebitda -200.99%
- Net Worth 26.03%
- Total Assets -39.99%
About Bennevolance Pharma
Bennevolance Pharma Private Limited (BPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 May 2004 and has a history of 20 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Tirupati Medicaments Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2004PTC044162
-
Company No.
044162
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 May 2004
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Bennevolance Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamaljeet Jaiswal
|
Additional Director | 24-May-2004 | Current |
|
Ratna Jaiswal
|
Director | 18-Nov-2011 | Current |
Financial Performance of Bennevolance Pharma.
Bennevolance Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.72% decrease. The company also saw a substantial fall in profitability, with a 24.3% decrease in profit. The company's net worth Soared by an impressive increase of 26.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bennevolance Pharma?
In 2023, Bennevolance Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Iscon Life Sciences Private LimitedKamaljeet Jaiswal and Ratna Jaiswal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bennevolance Pharma?
Unlock and access historical data on people associated with Bennevolance Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bennevolance Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bennevolance Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
